With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

Chronic obstructive lung disease, also known as chronic obstructive pulmonary disease (COPD), is a general term for a group ...

Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.

COPD (Chronic Obstructive Pulmonary Disease) is a lung disease that causes breathing difficulties, chronic cough, and mucus.

2024 — Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -- dupilumab -- that showed rapid and ...

Emphysema is one of the most common respiratory diseases in Britain and causes progressive ... new options to patients with COPD (an umbrella term for chronic bronchitis and emphysema), a severely ...

A flare-up in chronic obstructive pulmonary disease (COPD) can be predicted through changes in a person's voice, a new study ...

Fibrosis and accumulation of senescent cells are common tissue changes associated with aging. Here, we show that the CDK ...

Bronchitis is inflammation of the inner mucus lining of the bronchial tubes in the lungs. A nagging cough is one of the most prevalent bronchitis symptoms. A cough usually starts as dry but ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) ...

Chronic obstructive pulmonary disease (COPD) is a group of lung diseases that include emphysema and chronic bronchitis. COPD prevents airflow to the lungs, causing sufferers to struggle to breathe.